Objective To evaluate the clinical efficacy of valve-in-valve transcatheter mitral valve replacement for the management of degenerated bioprosthetic mitral valves. Methods This study retrospectively analyzed the clinical data of patients who underwent transcatheter mitral valve replacement due to degenerated bioprosthetic mitral valves at the First Affiliated Hospital of Zhengzhou University from 2020 to 2023. The analysis included baseline characteristics, surgical details, perioperative complications, and hemodynamic changes during the early postoperative period and subsequent follow-up. Results A total of 31 patients were included in the study, comprising 7 males and 24 females, with an average age of (66.57±9.32) years. The average duration since the initial surgical placement of the bioprosthetic valves was (9.92±3.71) years. The procedures included 7 patients utilizing the transfemoral venous-atrial septal approach and 24 patients employing the transapical approach. All patients exhibited significant improvement in cardiac function postoperatively, with a reduction in the number of patients classified as New York Heart Association (NYHA) grade Ⅲ or Ⅳ and those with moderate to severe tricuspid valve regurgitation. Echocardiographic assessments revealed a decrease in peak flow velocity across the mitral valve and a reduction in the average transvalvular pressure gradient, while left ventricular ejection fraction remained unchanged. One patient experienced a recurrent stroke and died on the fifth postoperative day; however, the remaining patients were discharged uneventfully, without complications such as cardiac death, left ventricular outflow tract obstruction, or pacemaker implantation. During a median follow-up period of 12 months, no adverse events were reported, and hemodynamic stability was maintained. Conclusion Valve-in-valve transcatheter mitral valve replacement is a safe and effective option for patients with degenerated bioprosthetic mitral valves, demonstrating favorable hemodynamic outcomes and satisfactory short-term clinical results.

Bronchial asthma(hereinafter referred to as asthma)is a common chronic respiratory disease characterized by airway inflammation,airway hyperresponsiveness,and airway remodeling.Its pathogenesis is highly complex and heterogeneous,involving multiple factors such as genetics,immunity,and environmental exposure.Currently,therapeutic options for asthma remain relatively limited,making it an urgent priority to explore its underlying mechanisms,identify effective treatment strategies,and develop new drugs.In this context,the establishment of animal models for asthma plays an irreplaceable and crucial role.However,to date,no single ideal animal model has been able to fully and accurately replicate all the features of the onset and progression of human asthma.This study systematically reviews the research progress over the past five years in the establishment methods of asthma animal models.It provides a detailed overview of commonly used experimental animals(such as mice,rats,and guinea pigs),frequently used sensitizing agents(including ovalbumin,house dust mite,lipopolysaccharide,and toluene diisocyanate),and the methods for establishing asthma models using these animals and sensitizers.This study also presents an objective evaluation of the advantages,limitations,and applicability of each model.Evaluation criteria for asthma models are summarized across multiple dimensions,including behavioral assessments,pulmonary function,histopathology,immunological indicators,and pharmacodynamics.Although methods for establishing refractory asthma models remain underdeveloped,several strategies for modeling refractory asthma have been summarized through a review of relevant literature,aiming to provide useful references for related research.Based on current scientific and technological advancements,it is anticipated that future research on asthma animal models will focus more on clinical relevance,technological innovation,and multidisciplinary integration.Specifically,future models are expected to adopt multi-sensitizer induction protocols,apply cutting-edge tools such as gene editing,enhance clinical relevance and promote diversification and personalization of models.Furthermore,advanced technologies such as bioimaging and biosensing are anticipated to enable dynamic monitoring of airway inflammation and remodeling.Organ-on-a-chip platforms may also be explored as potential alternatives to traditional animal models.The ultimate goal is to develop multifactorial,composite models that better simulate the complexity and heterogeneity of human asthma.

Bronchial asthma(hereinafter referred to as asthma)is a common chronic respiratory disease characterized by airway inflammation,airway hyperresponsiveness,and airway remodeling.Its pathogenesis is highly complex and heterogeneous,involving multiple factors such as genetics,immunity,and environmental exposure.Currently,therapeutic options for asthma remain relatively limited,making it an urgent priority to explore its underlying mechanisms,identify effective treatment strategies,and develop new drugs.In this context,the establishment of animal models for asthma plays an irreplaceable and crucial role.However,to date,no single ideal animal model has been able to fully and accurately replicate all the features of the onset and progression of human asthma.This study systematically reviews the research progress over the past five years in the establishment methods of asthma animal models.It provides a detailed overview of commonly used experimental animals(such as mice,rats,and guinea pigs),frequently used sensitizing agents(including ovalbumin,house dust mite,lipopolysaccharide,and toluene diisocyanate),and the methods for establishing asthma models using these animals and sensitizers.This study also presents an objective evaluation of the advantages,limitations,and applicability of each model.Evaluation criteria for asthma models are summarized across multiple dimensions,including behavioral assessments,pulmonary function,histopathology,immunological indicators,and pharmacodynamics.Although methods for establishing refractory asthma models remain underdeveloped,several strategies for modeling refractory asthma have been summarized through a review of relevant literature,aiming to provide useful references for related research.Based on current scientific and technological advancements,it is anticipated that future research on asthma animal models will focus more on clinical relevance,technological innovation,and multidisciplinary integration.Specifically,future models are expected to adopt multi-sensitizer induction protocols,apply cutting-edge tools such as gene editing,enhance clinical relevance and promote diversification and personalization of models.Furthermore,advanced technologies such as bioimaging and biosensing are anticipated to enable dynamic monitoring of airway inflammation and remodeling.Organ-on-a-chip platforms may also be explored as potential alternatives to traditional animal models.The ultimate goal is to develop multifactorial,composite models that better simulate the complexity and heterogeneity of human asthma.

The incidence and mortality rates of hepatocellular carcinoma(HCC)remain high in China,and the application of surgical resection is often limited due to the fact that most patients are in the advanced stage at the time of confirmed diagnosis.This article reviews commonly used advanced locoregional therapies for HCC and the advances in mainstream techniques such as local ablation(radiofrequency ablation,microwave ablation,irreversible electroporation,and cryoablation),intravascular intervention(transcatheter arterial chemoembolization,hepatic arterial infusion chemotherapy,and Y90 hepatic arterial infusion chemotherapy),and radiotherapy(CyberKnife,proton therapy,and heavy-ion therapy),and a multidimensional decision-making framework is constructed for HCC locoregional therapy by comparing treatment principles,indications,limitations,and clinical data of these techniques.This article aims to provide evidence-based support for persistent dilemmas in clinical decision-making,promote the role of locoregional therapies in clinical practice,and propose the directions for future research and clinical application.This article also establishes a comprehensive clinical roadmap for HCC locoregional therapy,which helps to address current challenges regarding technique selection and delineate future directions for innovation,in order to reshape the treatment of HCC through technological integration and paradigm innovation.

Objective To investigate the effect of postoperative reduction quality in femoral neck fracture internal fixation on mechanical properties of the femoral head from the perspective of trabecular bone biomechanics.Methods From patients who underwent hip replacement surgery for femoral neck fractures,a total of 26 femoral head slice specimens were obtained.The central axis of the primary compressive trabeculae was defined as the 0° group,with the intersection point of the primary compressive trabeculae and the femoral calcar serving as the center.By rotating the specimens to simulate different reduction angles,the cut femoral head slice specimens were randomly divided into five groups:-10°,-5°,0°,5°,and 10°,representing femoral heads with varying reduction qualities.The specimens were subjected to single compression load tests and fatigue load tests.The load was set from 70 N to 1 400 N,at a frequency of 1 Hz,with 10 000 cycles.Axial stiffness,displacement,and the number of collapse cycles were measured,to compare the biomechanical properties of femoral head specimens under different reduction qualities.Results There were differences in the axial stiffness,displacement,and number of collapse cycles among the femoral head specimens in different groups.Under 800 N load,the axial stiffness of 0° group was significantly greater than that of±10° groups(P＜0.05).The axial stiffness of 0° group was also greater than that of the±5° groups,but the differences were not statistically significant(P＞0.05).The axial stiffness of±5° groups was greater than that of±10° groups(P＜0.05).0° group had a lower displacement than±5° groups and±10° groups.However,the differences in displacement between 0° group and±5° groups were not statistically significant(P＞0.05),while the differences between the 0° group and±10° groups were statistically significant(P＜0.05).The differences in displacement between±5° groups and±10° groups were also statistically significant(P＜0.05).0° group had a significantly higher number of collapse cycles than±10° groups(P＜0.05).The number of collapse cycles in 0° group was also higher than that in±5° groups,but the differences were not statistically significant(P＞0.05).The number of collapse cycles in±5° groups was significantly higher than that±10° groups(P＜0.05).Conclusions The quality of reduction after internal fixation of femoral neck fractures significantly affects the biomechanical properties of the femoral head.This study provides a scientific basis for optimizing treatment and postoperative management,aiming to improve clinical outcomes and patients' quality of life.

Objective To investigate the effect of postoperative reduction quality in femoral neck fracture internal fixation on mechanical properties of the femoral head from the perspective of trabecular bone biomechanics.Methods From patients who underwent hip replacement surgery for femoral neck fractures,a total of 26 femoral head slice specimens were obtained.The central axis of the primary compressive trabeculae was defined as the 0° group,with the intersection point of the primary compressive trabeculae and the femoral calcar serving as the center.By rotating the specimens to simulate different reduction angles,the cut femoral head slice specimens were randomly divided into five groups:-10°,-5°,0°,5°,and 10°,representing femoral heads with varying reduction qualities.The specimens were subjected to single compression load tests and fatigue load tests.The load was set from 70 N to 1 400 N,at a frequency of 1 Hz,with 10 000 cycles.Axial stiffness,displacement,and the number of collapse cycles were measured,to compare the biomechanical properties of femoral head specimens under different reduction qualities.Results There were differences in the axial stiffness,displacement,and number of collapse cycles among the femoral head specimens in different groups.Under 800 N load,the axial stiffness of 0° group was significantly greater than that of±10° groups(P＜0.05).The axial stiffness of 0° group was also greater than that of the±5° groups,but the differences were not statistically significant(P＞0.05).The axial stiffness of±5° groups was greater than that of±10° groups(P＜0.05).0° group had a lower displacement than±5° groups and±10° groups.However,the differences in displacement between 0° group and±5° groups were not statistically significant(P＞0.05),while the differences between the 0° group and±10° groups were statistically significant(P＜0.05).The differences in displacement between±5° groups and±10° groups were also statistically significant(P＜0.05).0° group had a significantly higher number of collapse cycles than±10° groups(P＜0.05).The number of collapse cycles in 0° group was also higher than that in±5° groups,but the differences were not statistically significant(P＞0.05).The number of collapse cycles in±5° groups was significantly higher than that±10° groups(P＜0.05).Conclusions The quality of reduction after internal fixation of femoral neck fractures significantly affects the biomechanical properties of the femoral head.This study provides a scientific basis for optimizing treatment and postoperative management,aiming to improve clinical outcomes and patients' quality of life.

The incidence and mortality rates of hepatocellular carcinoma(HCC)remain high in China,and the application of surgical resection is often limited due to the fact that most patients are in the advanced stage at the time of confirmed diagnosis.This article reviews commonly used advanced locoregional therapies for HCC and the advances in mainstream techniques such as local ablation(radiofrequency ablation,microwave ablation,irreversible electroporation,and cryoablation),intravascular intervention(transcatheter arterial chemoembolization,hepatic arterial infusion chemotherapy,and Y90 hepatic arterial infusion chemotherapy),and radiotherapy(CyberKnife,proton therapy,and heavy-ion therapy),and a multidimensional decision-making framework is constructed for HCC locoregional therapy by comparing treatment principles,indications,limitations,and clinical data of these techniques.This article aims to provide evidence-based support for persistent dilemmas in clinical decision-making,promote the role of locoregional therapies in clinical practice,and propose the directions for future research and clinical application.This article also establishes a comprehensive clinical roadmap for HCC locoregional therapy,which helps to address current challenges regarding technique selection and delineate future directions for innovation,in order to reshape the treatment of HCC through technological integration and paradigm innovation.

Ginseng Radix et Rhizoma（GRR） has the function of replenishing vital energy and can lighten the body and prolong the life when taken for a long time， which is suitable for the development of anti-aging products， so this paper intends to sort out the progress of anti-aging research on GRR. After combing， the results of modern studies have shown that a variety of components in GRR have anti-aging effect， which can prolong the lifespan of aging animal models， as well as delay the aging of various systems. The anti-aging mechanisms mainly include anti-cellular senescence， anti-oxidative stress， inhibiting telomere shortening， maintaining mitochondrial homeostasis and so on. The anti-aging ingredients of GRR involved in the researches mainly include ginsenoside Rg₁ and ginsenoside Rb₁， in addition， ginsenoside Rg₃， ginsenoside Rd， ginsenoside Rg₂， ginsenoside Re， ginsenoside Rb₂， oligosaccharides of GRR， polysaccharides of GRR， water extract of GRR， total saponins of Panax ginseng stems and leaves are also included. Therefore， under current background of population aging， the in-depth development of GRR and its transformation into anti-aging products are of great significance for delaying senility and improving the health conditions of aging population.

Cognitive dysfunction is the main manifestation of aging,which has become a hot topic of global concern as aging inten-sifies.This article proposes that essence is the origin of life,qi is the driving force of life,and spirit is the embodiment of life.Guided by the qiluo theory of essence,qi,and spirit,the key pathogenesis and corresponding treatment methods of cognitive impairment caused by aging are proposed:kidney essence deficiency and brain marrow insufficiency are the fundamental,primordial qi deficiency and brain meridian obstruction are the key,brain spirit dystrophy and spirit activity dysfunction are the manifestations;the treatment is to tonify the kidney and essence to fill brain marrow,warm and nourish primordial qi to unblock brain meridians,enhance brain sprit to improve spirit activity,expecting to be beneficial for delaying and preventing aging-caused cognitive impairment.

The complement lectin pathway is an important means to exert immune effect.Ficolin and Mannan-binding lectin(MBL)are the initiators of complement pathway.Both structure and function are very similar.They can activate the complement path-way by recognizing certain substances on the surface of pathogens,emphasizing phagocytosis or directly kill and dissolve related patho-gens,thereby playing an important role in the immune system,especially in fighting infection.The respiratory system diseases are mostly infectious diseases.In recent years,there have been reports that ficolin/MBL is related to many other respiratory diseases.This article discusses the related research of ficolin/MBL and respiratory diseases,hopes to provide theoretical support for related research.